Profile data is unavailable for this security.
About the company
Shandong Boan Biotechnology Co Ltd is a China-based company primarily engaged in biopharmaceuticals. The Company is engaged in the development, production and commercialisation of therapeutic antibodies, focusing on the therapeutic areas of oncology, metabolism, autoimmunology and ophthalmology. The Company has three main technology platforms: a fully human antibody transgenic mouse and phage display technology platform, a bispecific T-cell Engager technology platform, and an antibody drug coupling (ADC) technology platform. The Company operates mainly in the domestic Chinese market and overseas markets.
- Revenue in HKD (TTM)857.13m
- Net income in HKD36.28m
- Incorporated2013
- Employees714.00
- LocationShandong Boan Biotechnology Co LtdNo. 39 Keji AvenueHigh-Tech Industrial Development ZoneYANTAI ChinaCHN
- Websitehttps://www.boan-bio.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Essex Bio-Technology Ltd | 1.73bn | 313.18m | 2.51bn | 1.43k | 8.04 | 1.10 | 6.78 | 1.45 | 0.5508 | 0.5508 | 3.05 | 4.01 | 0.5596 | 2.96 | 2.84 | 1,196,360.00 | 10.10 | 10.28 | 13.56 | 13.62 | 89.50 | 87.73 | 18.05 | 18.70 | 1.82 | -- | 0.1135 | 17.49 | -3.87 | 5.47 | 11.61 | 0.3101 | -7.47 | 7.14 |
| Jacobson Pharma Corporation Ltd | 1.53bn | 302.58m | 2.54bn | 1.79k | 8.36 | 1.14 | 5.63 | 1.66 | 0.1519 | 0.1519 | 0.7698 | 1.12 | 0.4299 | 2.54 | 9.06 | 876,757.00 | 8.48 | 4.83 | 10.29 | 6.17 | 44.30 | 41.26 | 19.73 | 14.85 | 0.9023 | 10.21 | 0.286 | 57.09 | 7.43 | 0.0691 | 43.09 | 7.05 | 24.09 | 14.87 |
| SinoMab Bioscience Ltd | 0.00 | -163.48m | 2.62bn | 61.00 | -- | 8.26 | -- | -- | -0.151 | -0.151 | 0.00 | 0.2288 | 0.00 | -- | -- | 0.00 | -18.46 | -22.26 | -24.62 | -25.68 | -- | -- | -- | -3,832.94 | -- | -7.82 | 0.6265 | -- | 48.42 | -- | 23.85 | -- | -0.376 | -- |
| AIM Vaccine Co Ltd | 1.43bn | -304.78m | 3.79bn | 1.49k | -- | 1.01 | -- | 2.65 | -0.2507 | -0.2507 | 1.18 | 3.05 | 0.174 | 0.7724 | 1.12 | 931,534.60 | -3.71 | -8.04 | -6.66 | -12.31 | 71.80 | 79.64 | -21.32 | -39.38 | 0.5882 | -3.70 | 0.3341 | -- | 8.22 | 6.19 | 78.69 | -- | -7.20 | -- |
| Beijing Luzhu Biotechnology Co Ltd | 0.00 | -153.88m | 4.55bn | 197.00 | -- | 5.49 | -- | -- | -0.7667 | -0.7667 | 0.00 | 4.17 | 0.00 | -- | -- | 0.00 | -12.48 | -- | -13.69 | -- | -- | -- | -- | -- | 4.68 | -- | 0.2296 | -- | -- | -- | 32.53 | -- | -- | -- |
| Shandong Boan Biotechnology Co Ltd | 857.13m | 36.28m | 4.82bn | 714.00 | 121.78 | 1.93 | 36.55 | 5.63 | 0.0636 | 0.0636 | 1.51 | 4.01 | 0.2530 | 1.34 | 1.73 | 1,054,275.00 | 1.07 | -- | 1.41 | -- | 71.70 | -- | 4.23 | -- | 1.45 | 1.81 | 0.2827 | -- | 17.50 | -- | 161.31 | -- | -- | -- |
| VIVA Biotech Holdings | 2.08bn | 195.14m | 4.92bn | 2.09k | 32.59 | 1.11 | 9.78 | 2.37 | 0.0709 | 0.0709 | 0.6816 | 2.09 | 0.2612 | 4.24 | 4.94 | 1,008,351.00 | 3.22 | -1.28 | 3.81 | -1.56 | 37.44 | 34.30 | 12.33 | -4.94 | 1.44 | -- | 0.2283 | -- | -7.84 | 43.80 | 244.08 | -8.85 | 27.82 | -- |
| Tong Ren Tang Technologies Co Ltd | 7.87bn | 488.95m | 5.62bn | 3.89k | 11.50 | 0.6804 | 4.54 | 0.7145 | 0.3818 | 0.3818 | 6.14 | 6.45 | 0.482 | 0.8615 | 6.00 | 1,971,759.00 | 5.47 | 7.44 | 8.57 | 12.07 | 39.82 | 42.21 | 11.34 | 15.10 | 2.79 | -- | 0.1913 | 39.34 | 7.18 | 10.15 | -11.59 | 4.55 | -8.30 | 3.37 |
| Ocumension Therapeutics | 615.81m | -282.30m | 5.71bn | 505.00 | -- | 1.38 | -- | 9.27 | -0.3768 | -0.3768 | 0.8223 | 5.08 | 0.1571 | 4.30 | 3.35 | 1,259,321.00 | -7.20 | -24.03 | -7.62 | -25.71 | 42.58 | 58.38 | -45.84 | -400.90 | 4.86 | -- | 0.0223 | -- | 69.38 | 365.95 | 29.36 | -- | 213.01 | -- |
Data as of Feb 13 2026. Currency figures normalised to Shandong Boan Biotechnology Co Ltd's reporting currency: Hong Kong Dollar HKD
2.75%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Fund Advisorsas of 06 Feb 2026 | 3.46m | 0.56% |
| GF Fund Management Co., Ltd.as of 30 Jun 2025 | 2.10m | 0.34% |
| Caitong Fund Management Co., Ltd.as of 30 Jun 2025 | 1.98m | 0.32% |
| First Seafront Fund Management Co., Ltd.as of 30 Jun 2025 | 1.96m | 0.31% |
| BlackRock Advisors (UK) Ltd.as of 06 Feb 2026 | 1.54m | 0.25% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2025 | 1.53m | 0.25% |
| Broad Fund Management Co. Ltd.as of 30 Jun 2025 | 1.38m | 0.22% |
| China International Capital Corp. HK Asset Management Ltd.as of 30 Jun 2025 | 1.27m | 0.20% |
| SSgA Funds Management, Inc.as of 05 Feb 2026 | 957.60k | 0.15% |
| ICBC UBS Asset Management Co. Ltd.as of 30 Jun 2025 | 914.20k | 0.15% |
More ▼
Data from 30 Jun 2025 - 30 Jan 2026Source: FactSet Research Systems Inc.
